The Department of Radiology at New York University Langone Health (NYULH) invites applications at an Assistant or Associate Professor level to apply for a (tenure-track) faculty position for the next Director of Radiochemistry Lab. This is an opportunity to guide the planning and future directions of a state-of-the-art PET radiopharmaceutical facility. Research in the Department of Radiology is an integrated cross-disciplinary scientific, administrative, and educational home for imaging science across multiple disciplines including neuroscience, psychiatry and oncology research. The NYULH Department of Radiology (https://med.nyu.edu/radiology/research) has a strong record of innovation in imaging research, including the development and translation of unique PET radioligands. This is an outstanding opportunity for an energetic scientist with interest in areas that complement and enhance the current research strengths of the Department (see https://med.nyu.edu/radiology/research/areas-expertise/). The successful candidate is expected to oversee research associates and staff members involved in the cyclotron operation and PET radiochemistry for the production of clinical and preclinical PET biomarkers in compliance with internal procedures, cGMP, other FDA regulations and United States Pharmacopeia standards. He/She will be expected to develop a novel research program that includes strong intradepartmental and interdepartmental collaboration, as well as education. Available resources include: cyclotron, clinical PET/MR, preclinical PET-CT imaging systems, and MRI scanners. Responsibilities may also include assisting with the introduction of new radiotracers into clinical use, as well as radiochemistry assistance with IND applications. The ideal candidate should hold a PhD preferably in chemistry with excellent practical skills in radiochemical synthesis and methods, along with a broad understanding of organic chemistry and associated analytic techniques. Knowledge of current Good Manufacturing Practices (cGMP) for Positron Emission Tomography (PET) biomarker production and ALARA radiation safety procedures are strictly required. Previous demonstrated successful experience with short lived C-11 and F-18 radiochemistry is highly desirable. Primary responsibilities will include research, including generation of extramural funding and publication in peer-reviewed journals, and facility and laboratory management. Previous leadership, managerial, and educational experience are preferred. Rank will be commensurate with experience
The ideal candidate should hold a PhD preferably in chemistry, organic chemistry or related field
with excellent practical skills in radiochemical synthesis and methods, along with a broad
understanding of organic chemistry and associated analytic techniques.
10+ years of experience in Radiochemistry and clinical translation of small molecules, peptides and antibodies
Knowledge of currentGood Manufacturing Practices (cGMP) for Positron Emission Tomography (PET) biomarkerproduction and ALARA radiation safety procedures are strictly required.
Previous demonstrated successful experience with short lived C-11 and F-18 radiochemistry is highly desirable.
Internal Number: http://apply.interfolio.c
About New York University Langone Health
The New York University Langone Health, Department of Radiology operates a cutting edge research division, comprising the Center for Biomedical Imaging and the Center for Advanced Imaging Innovation and Research (CAI2R). Radiology research personnel includes more than 100 scientists, technologists, and administrators who work closely with practicing clinical faculty.
What We Do
We invent and build biomedical imaging technologies to address pressing clinical problems. Our research focuses on improving medical practice through advancement of magnetic resonance imaging (MRI), positron emission tomography combined with magnetic resonance (PET-MR), and computed tomography (CT).
We develop methods and tools that increase quality of imaging, deliver new or better information to clinicians, enable earlier diagnosis, and guide treatment. We also improve existing imaging technologies by increasing their speed, safety, and comfort.
We rapidly prototype and evaluate imaging hardware, build software packages, and engineer new image acquisition and reconstruction tools. In addition, we conduct preclinical and clinical studies to determine which research and deve...lopment directions have the greatest potential to fulfill unmet needs in the clinic.
Our research division brings together basic scientists, engineers, clinical radiologists, physicians, computer scientists, and medical imaging industry partners. We also work with colleagues at academic, medical, and industry research institutions across the U.S. and the globe.
Thanks to close collaboration with practicing clinicians and with manufacturers of imaging platforms, we bring our best advances to clinical practice at NYU Langone and to healthcare institutions—and patients—throughout the world.